Free Shipping on purchases over €100

Drasanvi Melatonina 1,9 Mg , 50 ml

Drasanvi Melatonin 1,9 Mg , 50 ml

Drasanvi Melatonin 1.9 mg is a health product whose active ingredient is melatonin. It is rapidly absorbed and distributed throughout the body and brain. It helps to reduce the disorders associated with insomnia and provides a restful sleep.

SKU: DR8436044513473
-39%
8.25
€13.50
€16.50
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Melatonin1.9 mg is a food supplement manufactured by Drasanvi laboratories. It has been created to help people who have problems falling asleep quickly.

Its only active ingredient is melatonin, a hormone that in its natural form is secreted by the hypothesis. It is regulated by the presence of light. Lack of this substance causes sleeping difficulties, as the biological clock that systematises the sleep-wake cycles is thrown out of control.

This product facilitates the synchronisation of circadian rhythms, which are behavioural, mental and physical changes that follow a 24-hour time span. These processes respond to light and darkness, which can cause jet lag in travellers.

The supplement is therefore used to alleviate jetlag, or jet lag, by helping the person affected to adapt quickly to the new time zone. It relieves the symptoms associated with jetlag (general tiredness, daytime sleepiness and difficulty falling asleep at night).

It is also considered beneficial for improving moods, boosting the immune system, protecting the skin and promoting good heart health. Despite all these properties, the supplement should not be used as a substitute for a varied diet and healthy lifestyle. The formula contains no gluten or added sugars.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.